bss

Generic: balanced salt solution

Labeler: alcon laboratories, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name bss
Generic Name balanced salt solution
Labeler alcon laboratories, inc.
Dosage Form SOLUTION
Routes
OPHTHALMIC
Active Ingredients

calcium chloride .48 mg/mL, magnesium chloride .3 mg/mL, potassium chloride .75 mg/mL, sodium acetate 3.9 mg/mL, sodium chloride 6.4 mg/mL, sodium citrate 1.7 mg/mL

Manufacturer
Alcon Laboratories, Inc.

Identifiers & Regulatory

Product NDC 0065-0795
Product ID 0065-0795_f56f90e2-cd68-445b-b8fb-74a53f0f2ca6
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020742
Listing Expiration 2026-12-31
Marketing Start 1969-03-28

Pharmacologic Class

Classes
blood coagulation factor [epc] calcium [cs] calculi dissolution agent [epc] cations divalent [cs] increased coagulation factor activity [pe] increased large intestinal motility [pe] inhibition large intestine fluid/electrolyte absorption [pe] inhibition small intestine fluid/electrolyte absorption [pe] magnesium ion exchange activity [moa] osmotic activity [moa] osmotic laxative [epc] phosphate binder [epc] phosphate chelating activity [moa] potassium compounds [cs] potassium salt [epc] stimulation large intestine fluid/electrolyte secretion [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 00650795
Hyphenated Format 0065-0795

Supplemental Identifiers

RxCUI
806392 806396
UPC
0300650795159
UNII
M4I0D6VV5M 02F3473H9O 660YQ98I10 4550K0SC9B 451W47IQ8X 1Q73Q2JULR

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name bss (source: ndc)
Generic Name balanced salt solution (source: ndc)
Application Number NDA020742 (source: ndc)
Routes
OPHTHALMIC
source: ndc

Resolved Composition

Strengths
  • .48 mg/mL
  • .3 mg/mL
  • .75 mg/mL
  • 3.9 mg/mL
  • 6.4 mg/mL
  • 1.7 mg/mL
source: ndc
Packaging
  • 15 mL in 1 BOTTLE (0065-0795-15)
  • 500 mL in 1 BOTTLE (0065-0795-50)
source: ndc

Packages (2)

0065-0795-15 15 mL in 1 BOTTLE (0065-0795-15) 0065-0795-50 500 mL in 1 BOTTLE (0065-0795-50)

Ingredients (6)

calcium chloride (.48 mg/mL) magnesium chloride (.3 mg/mL) potassium chloride (.75 mg/mL) sodium acetate (3.9 mg/mL) sodium chloride (6.4 mg/mL) sodium citrate (1.7 mg/mL)

Linked Drug Pages (1)

BSS ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["OPHTHALMIC"], "spl_id": "f56f90e2-cd68-445b-b8fb-74a53f0f2ca6", "openfda": {"upc": ["0300650795159"], "unii": ["M4I0D6VV5M", "02F3473H9O", "660YQ98I10", "4550K0SC9B", "451W47IQ8X", "1Q73Q2JULR"], "rxcui": ["806392", "806396"], "spl_set_id": ["4bd4d59c-eb3b-4a5e-9eb7-ae95b0a92bea"], "manufacturer_name": ["Alcon Laboratories, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "15 mL in 1 BOTTLE (0065-0795-15)", "package_ndc": "0065-0795-15", "marketing_start_date": "19690328"}, {"sample": false, "description": "500 mL in 1 BOTTLE (0065-0795-50)", "package_ndc": "0065-0795-50", "marketing_start_date": "19690328"}], "brand_name": "BSS", "product_id": "0065-0795_f56f90e2-cd68-445b-b8fb-74a53f0f2ca6", "dosage_form": "SOLUTION", "pharm_class": ["Blood Coagulation Factor [EPC]", "Calcium [CS]", "Calculi Dissolution Agent [EPC]", "Cations", "Divalent [CS]", "Increased Coagulation Factor Activity [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Increased Large Intestinal Motility [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]", "Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]", "Magnesium Ion Exchange Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Activity [MoA]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Osmotic Laxative [EPC]", "Phosphate Binder [EPC]", "Phosphate Chelating Activity [MoA]", "Potassium Compounds [CS]", "Potassium Salt [EPC]", "Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]"], "product_ndc": "0065-0795", "generic_name": "balanced salt solution", "labeler_name": "Alcon Laboratories, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "BSS", "active_ingredients": [{"name": "CALCIUM CHLORIDE", "strength": ".48 mg/mL"}, {"name": "MAGNESIUM CHLORIDE", "strength": ".3 mg/mL"}, {"name": "POTASSIUM CHLORIDE", "strength": ".75 mg/mL"}, {"name": "SODIUM ACETATE", "strength": "3.9 mg/mL"}, {"name": "SODIUM CHLORIDE", "strength": "6.4 mg/mL"}, {"name": "SODIUM CITRATE", "strength": "1.7 mg/mL"}], "application_number": "NDA020742", "marketing_category": "NDA", "marketing_start_date": "19690328", "listing_expiration_date": "20261231"}